The global photomedicine market is anticipated to grow at a considerable CAGR of 7% during the forecast period (2022-2028). The key companies operating in the industry are highly inclined towards the adoption of different growth strategies including capacity expansion, partnerships, mergers and acquisitions, geographical expansion, new product launches, and product innovation to remain competitive in the marketplace. For instance,
- In December 2020, Cellaria Inc in partnership with Spring Lab, Northeastern University, has been receipt of a National Institutes of Health (NIH) R01 has granted to extend and advance application for hard-to-treat cancers by innovative new photomedicine-based therapies. This partnership has been provided with $3.2M funding to develop precision therapeutics in relation with tailored to the requirements of specific patient populations. Cellaria Inc. has also provided omics data, to determine that which biomarkers are most actionable when it comes in contact with drug-resistant cells and while applying them to photomedicine.
- In January 2020, Sebacia, Inc., launched Sebacia Microparticles in the US for the treatment of acne. This new microparticle was developed in collaboration with researchers from the Wellman Center of Photomedicine and also cleared the FDA approval. The new microparticles will also be using it and laser energy in dermatology. The company has also acquired Sienna Biopharmaceuticals ‘SNA-001 (silver photo particle technology) effectively resolving outstanding patent litigation between the firms.
To Request a Sample of our Report on Photomedicine Market: https://www.omrglobal.com/request-sample/photomedicine-market-size
Market Coverage
- The market number available for – 2021-2028
- Base year- 2021
- Forecast period- 2022-2028
Segment Covered-
- By Application
- By Technology
Regions Covered-
- North America
- Europe
- Asia-Pacific
- Rest of the World
- Competitive Landscape- Alma Lasers GmbH, BIOLASE, Inc., biolitecAG, Bright Medicine, Koninklijke Philips N.V., NinePoint Medical, Inc., Lumenis Ltd., Quantel Medical, and THOR Photomedicine Ltd., and others.
A full Report of Photomedicine Market is Available @ https://www.omrglobal.com/industry-reports/photomedicine-market-size
Photomedicine Market Report Segment
By Application
- Dermatology
- Ophthalmology
- Dentistry
- Oncology
- Wound Healing
- Others (Surgical Procedures)
By Technology
- Laser
- Bioptron Light Therapy
- Full Spectrum Light
- Dichroic Lamps
- Light Emiting Diodes (LED) & Fluorescent Lamps
- Polychromatic Polarized Light
Photomedicine Market Report by Region
North America
- United States
- Canada
Europe
- UK
- Germany
- Spain
- France
- Italy
- Rest of Europe
Asia-Pacific
- India
- China
- Japan
- South Korea
- Rest of APAC
Rest of the World
- Latin America
- Middle East and Africa
Company Profiles
- Abbott
- Alma Lasers GMBH
- AngioDynamics, Inc.
- Aura Medical Group Pty Ltd.
- BIOLASE, Inc.
- biolitec AG
- Candela Corp.
- Carl Zeiss Meditec AG
- IRIDEX Corp.
- Koninklijke Philips N.V.
- LightScalpel, Inc.
- Lumenis Be Ltd.
- NinePoint Medical, Inc.
- Novartis AG
- Quantel Medical
Reasons to buy from us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/photomedicine-market-size
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
